# Effects of VSL#3 on Metabolic, Endocrine, Lipidomic and Inflammatory Parameters of Pediatric Patients With BMI>90°

> **NCT01650025** · NA · COMPLETED · sponsor: **Bambino Gesù Hospital and Research Institute** · enrollment: 48 (actual)

## Conditions studied

- Obesity

## Interventions

- **DIETARY_SUPPLEMENT:** VSL#3 active probiotic
- **OTHER:** VSL#3 placebo

## Key facts

- **NCT ID:** NCT01650025
- **Lead sponsor:** Bambino Gesù Hospital and Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2013-08
- **Final completion:** 2013-12
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2017-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01650025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01650025, "Effects of VSL#3 on Metabolic, Endocrine, Lipidomic and Inflammatory Parameters of Pediatric Patients With BMI>90°". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01650025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*